4-(2-Chloroethyl)morpholine hydrochloride

We are 4-(2-Chloroethyl)morpholine hydrochloride CAS:3647-69-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-(2-Chloroethyl)morpholine hydrochloride
CAS.NO:3647-69-6
Synonyms:4-(2-Chloroethyl)morpholine hydrochloride
Morpholine, 4-(2-chloroethyl)-, hydrochloride
N-(2-Chloroethyl)morpholine hydrochloride
2-Morpholinoethyl Chloride Hydrochloride
Molecular Formula:C6H13Cl2NO
Molecular Weight:186.08000
 
Physical and Chemical Properties:
Density:1.088
Melting point:180-185ºC
Boiling point:202.8ºC
Flash point:76.4ºC
 
Specification:
Appearance:White to off-white crystalline solid Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Pharmaceutical intermediate

4-(2-Chloroethyl)morpholine hydrochloride


Related News: Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.N-[[[2-(Aminooxy)ethyl]amino]sulfonyl]carbamic acid 1,1-dimethylethyl ester Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.4'-metoxiacetoacetanilida CAS:5437-98-9 After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API.1-amino-2- (isopropilsulfonil) benceno CAS:76697-50-2 CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.

Related Products
Product Name
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan View Details
Methyl 2-cyclohexyl-2-hydroxy-2-phenylacetate View Details
Trifluoroacetic anhydride View Details
TETRAFLUOROSUCCINIC ACID Cas:377-38-8 manufacturer 2-Fluoro-5-nitropyridine manufacturer 5α-androst-16-en-3α-ol manufacturer Ethyl 3-chloro-4-fluorobenzoate manufacturer 2-Ethylacrolein manufacturer